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Abstract
Apoptosis can be induced or inhibited by viral proteins, it can form part of the host defense against virus infection,
or it can be a mechanism for viral spread to neighboring cells. Canine distemper virus (CDV) induces apoptotic
cells in lymphoid tissues and in the cerebellum of dogs naturally infected. CDV also produces a cytopathologic
effect, leading to apoptosis in Vero cells in tissue culture. We tested canine distemper virus, a member of the
Paramyxoviridae family, for the ability to trigger apoptosis in HeLa cells, derived from cervical cancer cells resistant
to apoptosis. To study the effect of CDV infection in HeLa cells, we examined apoptotic markers 24 h post
infection (pi), by flow cytometry assay for DNA fragmentation, real-time PCR assay for caspase-3 and caspase-8
mRNA expression, and by caspase-3 and -8 immunocytochemistry. Flow cytometry showed that DNA
fragmentation was induced in HeLa cells infected by CDV, and immunocytochemistry revealed a significant
increase in the levels of the cleaved active form of caspase-3 protein, but did not show any difference in
expression of caspase-8, indicating an intrinsic apoptotic pathway. Confirming this observation, expression of
caspase-3 mRNA was higher in CDV infected HeLa cells than control cells; however, there was no statistically
significant change in caspase-8 mRNA expression profile. Our data suggest that canine distemper virus induced
apoptosis in HeLa cells, triggering apoptosis by the intrinsic pathway, with no participation of the initiator caspase
-8 from the extrinsic pathway. In conclusion, the cellular stress caused by CDV infection of HeLa cells, leading to
apoptosis, can be used as a tool in future research for cervical cancer treatment and control.
Keywords: Apoptosis, Canine distemper virus, Caspase, Cervical tumor, HeLa cell, HPV
Background
Apoptosis is a regulated form of cell death which occurs
during physiological conditions. It plays a critical role in
the homeostasis of multicelular organisms, and constitu-
tes a common pathway for cell replacement, tissue
remodeling, damaged cell removal and elimination of
cancer cells [1]. It is a complex process which involves
the participation of caspases, activation of proapoptotic
genes, and inhibition of antiapoptotic proteins. Cells
undergoing apoptosis present typical morphological
characteristics, including membrane blebbing, chromatin
condensation, cell shrinkage and apoptotic body forma-
tion [2].
Apoptosis is triggered by sequential activation of cas-
pases, a group of cysteine proteases, and proceeds pri-
marily through two pathways. The extrinsic pathway
involves activation of caspase-8 and is initiated by ligand
interaction with death receptors, while the intrinsic
pathway is activated by an imbalance between proapop-
totic and antiapoptotic proteins from Bcl-2 family in
mitochondria and cytosol, resulting in release of cyto-
chrome c from mitochondria, which in turn activates
caspase-9 [3]. Both caspase-8 and caspase-9 activate cas-
pase-3, which along with other effectors caspases cleave
critical cellular proteins, resulting in apoptosis [3].
Many viral proteins can influence the cellular path-
ways that control cell proliferation and apoptosis. Some
viral proteins trigger apoptotic cell death, and this may
be important in host defense and viral spread. In other
cases, viral proteins inhibit apoptosis [4].
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HeLa cells, derived from a cervical tumor, encode
apoptosis inhibitor proteins E6 and E7, oncoproteins
expressed by high-risk human papillomavirus (HPV),
among them the HPV18 type [5,6]. HPV E6 protein tar-
get p53, a tumor suppressor protein that regulates the
cell cycle. The E6 protein binding to p53 causes p53
inactivation by its degradation, turning off its function
[6,7]. On the other hand, the HPV E7 protein acts by
binding to members of the Rb (retinoblastoma protein)
tumor suppressor protein family, inhibiting its activity of
controlling cell division [8-10]. HPV E6 and E7 are
related to the resistence of HeLa cells apoptosis [11,12].
Canine distemper virus (CDV), a negative-stranded RNA
belonging to the genus Morbillivirus, family Paramyxoviri-
dae causes both cytopathologic infection and persistent
infections in vivo and in vitro [13,14]. CDV has been
shown to induce apoptosis in cerebellum and lymphoid
tissue of naturally infected dogs [15], through the extrinsic
pathway, activating caspase -8 and caspase -3 gene expres-
sion [16]. In addition, it was observed that CDV cause
apoptosis of Vero cells, also by triggering the extrinsic
pathway, with caspase -8 and caspase -3 activation [17,18].
The main objectives of this study were to determine if
CDV is able to induce apoptosis in cultured HeLa cells,
and use CDV and its proteins as a prospective research
line for cervical cancer treatment and control.
Materials and methods
Cell Culture
HPV18-positive HeLa cells (ATCC®, CCL-2™, Virgínia,
USA) were cultured on 24 well plates or in 33 and 100
mm plates (TPP®, Trasadingen, Switzerland) to approxi-
mately 70%-80% confluence in DMEM medium (Sigma)
supplemented with 10 mmol/l HEPES and 5% fetal
bovine serum (Atlanta Biologicals) in a humidified
atmosphere at 37°C and 5% CO2.
CDV infection of HeLa cells
Prior to CDV infection, approximately 25.000 HeLa
cells/cm2 were seeded into 24 well cassettes for immu-
nocytochemistry assay, on 100 mm plate for mRNA
analysis, and on 33 mm plate for flow-cytometry analysis
and incubated overnight. Each well/plate, with approxi-
mately 70-80% of confluence, was infected with 300 μl
of CDV-Lederle strain, in a proportion of 2 parts serum
free medium to 1 part CDV, at a multiplicity of infec-
tion of 0.1. After 1 h of virus adsorption, media was
removed and fresh complete medium was applied. After
24 h the cells were processed for immunocytochemistry,
flow-cytometry and real-time PCR procedures.
Immunocytochemistry for caspase -3 and -8
After HeLa infection medium was removed at 24 hours
post infection, and cells washed 2 X with phosphate
buffered saline (PBS) containing 0.9 mM CaCl2 and 0.5
mM MgCl2. Cells fixed with 4% paraformaldehyde for at
least 4 hours at 4°C. Coverslips containing fixed cells
were washed three times with Tris buffered saline (TBS-
50 mM Tris-HCl, 0,15 M NaCl, 2%) pH 7.6, and then
permeabilized with TBS containing 2% Bovine serum
albumin (BSA) and 0.1% Triton X for 10 minutes. The
first step was the inhibition of endogenous peroxidase in
order to avoid its reaction with the substrate outside of
the specific antigenic sites. For this, cells were incubated
for 5 minutes with Peroxidase Block (NovocastraTM
Peroxidase Detection System - RE7101), and then
washed twice with TBS. The second step was the incu-
bation for 5 minutes with a blocking protein (Novocas-
traTM Peroxidase Detection System - Protein Block -
RE7102) to suppress non-specific binding of subsequent
reagents. Subsequently cells were washed twice with
TBS for 5 minutes.
For caspase-3 localization, a monoclonal mouse anti-
human antibody (Novocastra Laboratories, Newcastle,
UK) was diluted 1:50 and applied for 1 hour at room
temperature in a moist chamber. This antibody recog-
nizes caspase-3 protein in its active form. For caspase-8
localization, a monoclonal mouse anti-human caspase-8
antibody (Novocastra Laboratories, Newcastle, UK) was
diluted 1:30 and applied for 1 hour at room temperature
in a moist chamber. This antibody recognizes caspase-8
protein in its active form. Cells were washed with TBS,
and incubated with biotinylated secondary antibody
(NovocastraTM Peroxidase Detection System - RE7103),
for 30 minutes at room temperature. After incubation
and washing the excess secondary antibody with TBS,
cells were then incubated for 30 minutes with streptavi-
din-HRP (NovocastraTM Peroxidase DetectionSystem-
RE7104). Finally, after washing cells with TBS, cells
were stained with 3,3 ‘-diaminobenzidine (DAB Chro-
mogen) (NovocastraTM Peroxidase Detection System)
in a buffer solution (NovocastraTM Peroxidase Detec-
tion System - RE7106).
The negative control consisted of HeLa cells incubated
with TBS+2%BSA, and positive control consisted of
HeLa cells incubated with 50 μM cisplatin. Caspase-3
positive cells were identified by the presence of a brown
color staining with sharp outlines and homogeneous in
the nucleus and cytoplasm; caspase-8 positive cells were
identified by the presence of a brown color staining
with sharp outlines and homogeneous in cytoplasm.
DNA fragmentation assay - Flow-Cytometry
Cell cycle status and quantification of DNA fragmenta-
tion (subdiploid DNA-content), apoptosis morphological
and biochemical characteristic, were performed by pro-
pidium iodide (PI) staining according to Nicolleti et al,
1991 [19]. After 24 hours of CDV infection, media was
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removed, and floating and adherent cells were lysed with
200 μl of a hypotonic fluorochrome solution - HFS (50
μg/mL PI in 0.1% sodium citrate plus 0.1% Triton X-
100) added onto a HeLa cell monolayer, protected
against light, and incubated at 4°C for 4 h. HeLa cells in
the supernatant of the removed media were centrifuged,
100 μl of HFS solution added, and cells were incubated
at 4°C for 4 h. The PI fluorescence of 20,000 individual
nuclei was measured using a FACScalibur flow cyt-
ometer (Becton Dickinson Immunocytometry Systems,
California, USA). Data were analyzed using FlowJo soft-
ware (TreeStar Inc, CA). For the positive control for
apopotosis, HeLa cells treated with 40 μM of cisplatin
were used. Cisplatin is an antitumor drug known for
inducing apoptosis in cancer cell line [20]. For negative
control HeLa cells with no treatment were used. All
samples were run in triplicate in at least three indepen-
dent experiments.
Real time PCR for caspase-3 and -8
Isolation of RNA
After 24 hours of CDV infection, HeLa cells were
washed with sterile PBS. Total RNA was isolated adding
1 ml of Trizol® reagent (Invitrogen Life Technologies,
Carlsbad, CA, United States of America - USA) to each
100 mm dish, following Trizol® manufacturer’s protocol.
At the end, the RNA pellet was briefly dried, redissolved
in RNase and DNase free water (Invitrogen Life Tech-
nologies, Carlsbad, CA, United States of America -
USA), and quantified using NanoDrop (Thermo Fisher
Scientific, Wilmington, Delaware, USA). RNA samples
were treated with Turbo DNA-free kit (Ambion Inc.,
Foster, CA, USA), and stored at -80°C until use.
Reverse transcription (RT)
First-strand complementary DNA (cDNA) was synthe-
sized from 2 μg total RNA using the Superscript first-
strand synthesis system (Invitrogen Inc., Carlsbad, CA,
USA). After denaturing the RNA template and primers
(25 pmol of each reverse oligonucleotide primer) were
incubated at 70°C for 10 min, and 40 U reverse tran-
scriptase was added in the presence of RT buffer (50
mM KCl, 20 mM Tris-HCl, pH 8.4), 4 μL dNTP mix
(250 μM each), 40 U RNase inhibitor and RNase-free
water to complete the final volume. The reaction
mixture (50 μL) was incubated at 43°C for 1 h, then
stopped at 4°C and used for PCR.
Real time PCR
Real-time PCR was carried out in an ABI Prism 7500
Sequence Detection System (Applied Biosystems, Foster
City, CA, USA), using the Power Sybr® Green Master
Mix Kit (Invitrogen Life Technologies, Carlsbad, CA,
USA).. All samples were run in duplicate. The PCR
parameters were 1 cycle at 50°C for 2 min, 1 cycle at
95°C for 10 min, 40 cycles at 95°C for 15 s and 60°C for
1 min. Primers used for PCR amplification of caspase-3,
-8 and Gapdh, are listed on Table 1. Gapdh (Glyceralde-
hyde-3-Phosphate Dehydrogenase) was used as a refer-
ence transcript to normalize target transcript expression.
Statistical analysis
DNA fragmentation assay results were expressed as the
mean ± SD of three independent experiments carried
out in triplicate. These data were analyzed using Stu-
dent’s t-test for paired comparisons between infected
cells and controls. Statistical significance was deter-
mined as p < 0.05.
PCR results were analyzed based on the ΔCT, which is
the primary source of data variability [21]. The CT
values were normally distributed and therefore they
were summarized as mean ± standard error and differ-
ences between the two groups were analyzed with the




Nuclear and cytoplasmatic immunoreactivity for cas-
pase-3 was present in HeLa cells infected by CDV, as
well as in control group treated with cisplatin (Figure 1a
and 2b). There was no immunoreactivity for caspase-8
in infected HeLa cells (Figure 1b); however it was
shown in HeLa cells treated with cisplatin (Figure 2d).
Control HeLa cells with no treatment were both, cas-
pase -3 and -8 negative (Figure 2a and 2c). Reaction
control of HeLa cells treated with 40 μM of cisplatin
incubated with TBS+2%BSA, instead the primary anti-
body, confirmed that there was no nonspecific staining
of the cells by the secondary antibody (Figure 3).
Table 1 Sequences of primers used in real time PCR
Primers Nucleotide Sequence Length (nt) Fragment size GenBank access number
HsCasp3Forw 5’- TGCATACTCCACAGCACCTGGTTA-3’ 24 82 bp NM_032991.2
HsCasp3Rev 5’-CATGGCACAAAGCGACTGGATGAA-3’ 24
HsCasp8Forw 5’- TTTCACTGTGTTAGCCAGGGTGGT A-3’ 24 84 bp NM_033355.3
HsCasp8Rev 5’- CCTGTAATCCCAGCACTTTGGGAG -3’ 24
HsGapdhForw 5’- TTCCAGGACCAAGATCCCTCCAAA - 3’ 24 86 bp XM_001725661
HsGapdhRev 5’- ATGGTGGTGAAGACACCAGTGAAC - 3’ 24
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DNA fragmentation assay - Flow-Cytometry
To investigate whether apoptosis was triggered by CDV
infection, DNA fragmentation and chromatin condensa-
tion were evaluated at 24 hours p.i. Significant increases in
DNA fragmentation were detected in HeLa cells infected
with CDV (57.68%) when comparing non-infected cells
(6.97%) (Table 2) (P < 0.05, Student’s t-test). Subdiploid
DNA content indicating DNA fragmentation, typical in
apoptotic cells, was observed in HeLa cells infected by
CDV and treated with cisplatin (Figure 4).
Real time PCR for caspase-3 and -8
Real-time PCR was performed to measure mRNA
expression using specific primers for caspase-3, caspase-
8 and the reference gene Gapdh. Expression of caspase-
3 mRNA increased in the CDV infected HeLa cell group
when compared to control cells (Figure 5). Interestingly,
caspase-8 mRNA expression did not change in CDV
infected HeLa cells compared to control cells.
Discussion
In summary, our results show that CDV infection in
HeLa cells induced apoptosis, probably by the intrinsic
pathway, ending with the activation of the effectors’ cas-
pase -3, as was observed in immunocytochemistry, and
real time PCR results.
HeLa cells, derived from a cervical tumor, encode
apoptosis inhibitor proteins E6 and E7, oncoproteins
expressed by high-risk HPV, among them the HPV18
type [5,6]. HPV E6 protein target p53 is a tumor sup-
pressor protein that regulates the cell cycle. The E6 pro-
tein binding to p53 causes p53 inactivation by its
degradation [6,7]. On the other hand, the HPV E7 pro-
tein acts by binding to members of the Rb tumor sup-
pressor protein family, which contribute to the control
of the cell division, process by modulating the function
of E2F transcription factors [8-10].
Apoptosis plays important roles in host defenses
against virus infection. Virus infected cells can show
changes in physiology. Cells may recognize virus parti-
cles at cell entry and viral proteins during viral replica-
tion and, in response, execute apoptosis in order to
block virus replication [22]. In addition, viral proteins
Figure 1 Immunocytochemistry of CDV infected cells :
Immunolocalization of caspase-3 (a) and caspase-8 (b) in HeLa cells
infected by CDV. The nuclear and cytoplasmatic brownish staining
indicates occurrence of active caspase-3 in infected cells (a). No
active caspase-8 is observed for infected cells (b) (Microscope
objective 40 × 0.75).
Figure 2 Immunocytochemistry positive and negative control: Immunolocalization of caspase-3 and caspase-8 (b and d) in HeLa cells
treated with 40 μM of cisplatin. Nuclear and cytoplasmatic brownish staining is observed for treated cultures indicating occurrence of active
caspase-3 (b) and caspase-8 (d) (Microscope objective 40 × 0.75). No staining for active caspase-3 (a) or caspase-8 (c) was observed for control
non-treated cells (Microscope objective 63 × 1.23).
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can interact with cell components which regulates cell
death, affecting apoptosis [23]. On the one hand it
seems that virus proteins block apoptosis to prevent
death of the host cell and so maximize virus replication
and facilitate a persistent infection. On the other hand it
seems that a growing number of viruses actively pro-
mote culminating a lytic infection and serving to spread
virus to neighbouring cells while evading host infamma-
tory responses [23-25].
It have been shown that apoptosis induced by canine
distemper virus occurs by the extrinsic pathway, activat-
ing initiator caspase-8 followed by the activation of
executioner caspase-3 [16,18]. Conversely, apoptosis in
HeLa cells caused by CDV infection did not show the
participation of caspase-8. From this, we can infer that
the CDV mechanisms of apoptosis in HeLa cells are dif-
ferent from the apoptosis mechanisms triggered in vivo
and in Vero cell line. However, HeLa CDV infection
may cause intracellular stress, which culminates with
the activation of the caspase cascade, leading to activa-
tion of the executioner caspase-3, and consequently cell
death. So, even the presence of oncoproteins E6 and E7,
which acts inactivating p53 and Rb proteins, did not
inhibit the activation of caspases [5,8]. Caspases are
initiators and effectors arm proteins of apoptosis, and
once the caspase cascade is activated, the process of cell
death is irreversible [3,26,27]. In conclusion, canine dis-
temper virus infection seems to activate the effector cas-
pase-3, leading to HeLa cells apoptosis, even in the
presence of E6 and E7 oncoproteins.
Conclusions
A relationship between viral infection and apoptosis has
been reported, with some viral infections inducing
Figure 3 Immunocytochemistry experiment control: No staining
was observed in the experiment negative control consisted of HeLa
cells treated with cisplatin (40 μM) incubated with TBS+2%BSA,
instead the primary antibody for caspase -3 or -8 (Microscope
objective 63 × 1.23).
Table 2 DNA fragmentation in HeLa cells infected by CDV
Treatment HeLa
Control 6.97 ± 3.56
Cisplatin 66.74 ± 3.32*
CDV 57.68 ± 3.08*
HeLa cells were incubated with 40 μM of cisplatin, CDV and vehicle (control),
at 37°C in a 5% CO2 atmosphere for 24 hours. DNA content was assessed by
flow-cytometric analysis of cells labeled with propidium iodide. Each data
represents the mean ± SD from 3 different experiments (* P < 0.05, Student
T-test).
Figure 4 Flow-Cytometry histogram: Subdiploid DNA content was assessed by staining with PI and flow cytometry analysis. CDV infection
induces apoptosis in HeLa cells (B). Cisplatin, positive control is demonstrated to cause apoptosis in positive control group (C). Negative control
did not show subdiploid DNA content (A). Subdiploid DNA content indicates DNA fragmentation, typical in apoptotic cells.
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apoptosis, while other inhibits apoptosis
[7,15,24,25,28,29]. Several viral proteins can induce
apoptosis of infected cells, such as VP3 protein of
chicken anemia virus (CAV), EIA protein of the adeno-
virus, HA protein of influenza virus [28,30,31], and HIV
[32]. There is no previous report identifying which CDV
protein could be involved in the apoptosis induction in
vivo, and in vitro. Further study is needed to evaluate
the CDV proteins, to specify which protein could be
involved and how it is related to apoptosis. Based on the
present findings we concluded that CDV infection
induces apoptosis in HeLa cells, by the intrinsic path-
way, through the activation of executor caspase-3, with-
out the participation of the initiator caspase-8.
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